All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
EyeCon 2024: Program co-chair Peter J. McDonnell, MD, marvels o
…
7 months ago
ophthalmologytimes.com
ASCRS 2024: George O. Waring IV, MD, shares early results of bilater
…
9 months ago
ophthalmologytimes.com
Real World Ophthalmology: A day packed with insights, innovation,
…
Sep 20, 2023
ophthalmologytimes.com
Visus Therapeutics CEO announces acquisition of ViewPoint Therapeu
…
Sep 30, 2022
ophthalmologytimes.com
Absolute Contraindications to Intravitreal Injection and Managin
…
Jul 27, 2022
ophthalmologytimes.com
Phase 3 LUGANO Trial explores EYP-1901’s potential to reduce tre
…
2 months ago
ophthalmologytimes.com
2:20
ASCRS 2024: What advancements in Light Adjustable Lens technolo
…
9 months ago
ophthalmologytimes.com
Retina Society 2024: Advances in AMD therapy highlight different m
…
4 months ago
ophthalmologytimes.com
Carl Zeiss Meditec to acquire Acri.Tec AG
Sep 4, 2007
ophthalmologytimes.com
AAO 2023: Neurotech's encapsulated cell therapy, NT-501
Nov 9, 2023
ophthalmologytimes.com
AAO 2024: Energy drinks and central retinal vein occlusions
2 months ago
ophthalmologytimes.com
Snowmass Retina and Eye 2025: Ronald Frenkel, MD, previews inte
…
5 days ago
ophthalmologytimes.com
ASRS 2024: Results from part 1 of the Phase 2/3 SIGLEC trial assess
…
6 months ago
ophthalmologytimes.com
Promising non-surgical treatment for early cataracts: Insights from
…
2 months ago
ophthalmologytimes.com
Mixing and Matching Monofocal Plus IOLs with Other Advanced Te
…
5 months ago
ophthalmologytimes.com
Patient Case #1: 58-year-old patient with open angle glaucoma utilizin
…
Jun 30, 2022
ophthalmologytimes.com
Anthony Wallace of Bausch Lomb talks about enVista Envy FDA app
…
3 months ago
ophthalmologytimes.com
Key Considerations for Selecting a Premium Intraocular Lens
Oct 10, 2023
ophthalmologytimes.com
ASRS 2024: Neurotech Pharmaceuticals update on the N
…
6 months ago
ophthalmologytimes.com
Trukera Medical rebranding allows team to expand into the broader c
…
Oct 11, 2022
ophthalmologytimes.com
Patient case 1: Neovascular AMD Patient Treated with Ranibizumab
…
11 months ago
ophthalmologytimes.com
ARVO 2024: A study on multi-ingredient oral supplement for dr
…
8 months ago
ophthalmologytimes.com
Retina Society 2024: Population pharmacokinetic modeling and si
…
4 months ago
ophthalmologytimes.com
Chris Brittain of Genentech discusses FDA approval to relaun
…
6 months ago
ophthalmologytimes.com
Perspectives on Latest Therapies: Faricimab and Aflibercept 8mg
3 months ago
ophthalmologytimes.com
MOA of Faricimab and 2-Year Data Review
Aug 30, 2022
ophthalmologytimes.com
AAO 2023: OTT166 progress: OcuTerra's diabetic retinopathy tr
…
Nov 3, 2023
ophthalmologytimes.com
AGS 2024: Glaucoma management is all about the patient
10 months ago
ophthalmologytimes.com
Overview of Biosimilars for Treating Retinal Diseases
Nov 28, 2023
ophthalmologytimes.com
Steps for implantation and refill of PDS with ranibizumab
6 months ago
ophthalmologytimes.com
See more videos
More like this
Feedback
Feedback